Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod

Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod
Study Demonstrated Neflamapimod Improved Cognition, Motor Function and Dementia Progression Relative to Placebo

GlobeNewswire

December 01, 2021



Melbourne, VIC, Australia; New Haven, CT, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Neuroscience...

Related Keywords

United States ,Australia ,Melbourne ,Victoria ,Rachel Colite Cogstate ,Paul Maruff ,Pharma Inc ,Cogstate Ltd ,Clinical Trial ,Lewy Bodies Used Cogstate Digital Assessments ,Data Quality Services ,Demonstrated Neflamapimod Improved Cognition ,Motor Function ,Dementia Progression Relative ,New Haven ,Lewy Bodies ,One Card Learning ,Gone Back ,Verbal Fluency ,Category Fluency ,Neuropsychiatric Inventory ,Clinical Dementia Rating Scale Sum ,Cogstate Chief Innovation ,Colite Cogstate ,